Search
Filter Results
- Resource Type
- Book2
- Article1
- Book Digital1
- Book Print1
- Article Type
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
- SearchWorks (biomedical subset) 1
-
Year
- Journal Title
- J Clin Invest1
Search Results
Sort by
- BookEvangeline B. Handog, Maria Juliet Enriquez-Macarayo, editors.Summary: This book sheds new light on pigmentary disorders in people with brown skin. Brown skin encompasses many races and ethnicities. Due to migration, people with brown skin are seen almost everywhere in the world. A wide variety of pigmentary disorders exists among this population but the most disturbing and challenging are melasma and vitiligo This book covers these two disorders, among people of brown skin, from the epidemiology to management, in a detailed yet easy-to-read and easy-to-use style.
Contents:
Part I. The Brown Skin
1. The concept of brown skin
2. Prevalent skin disorders in brown skin
Part II. Melasma in Brown Skin
3. Definition, incidence, and etiology of melasma in brown skin
4. Pathogenesis of melasma
5. Classification and clinical presentations of melasma in brown skin
6. Diagnosis of melasma in brown skin: Wood's Lamp, dermoscopy , and confocal microscopy
7. The histopathology of melasma in brown skin
8. The scoring aid: MASI and modified MASI
9. Differential diagnosis of melasma in brown skin
10. Melasma and comorbidities
11. Melanogenesis and new signaling regulatory for the treatment of melasma
12. Topical agents in melasma
13. Botanicals in melasma
14. Oral lightening agents
15. Chemical peeling for melasma
16. The role of lasers and light devices for the treatment of melasma
17. Iontophoresis and mesotherapy in melasma
18. Quality of life in melasma
Part III. Vitiligo in Brown Skin
19. Vitiligo: definition, incidence, etiology
20. Pathogenesis of vitiligo
21. Vitiligo classification and clinical presentations
22. Dermoscopy in vitiligo
23. The histopathology of vitiligo in brown skin
24. Differential diagnosis of vitiligo in brown skin
25. Comorbidities in vitiligo
26. Topical medications in vitiligo
27. Oral medications in vitiligo
28. Vitiligo management: procedural options
29. Phototherapy in vitiligo
30. Vitiligo and quality of life
Part IV. Other Management Options for Melasma and Vitiligo
31. Phtoprotection in brown skin
32. Camouflage for brown skin with melasma or vitiligo
33. What's in the pipeline for melasma and vitiligo.Digital Access Springer 2017 - ArticleDiamond RD, Krzesicki R, Jao W.J Clin Invest. 1978 Feb;61(2):349-59.Large forms of Candida are characteristically present in invasive lesions and are often cleared by host defenses. Therefore, an in vitro system was developed to study interactions between leukocytes and pseudohyphae. By light, phase contrast, and electron microscopic observations, in the absence of serum, neutrophils attached to and spread over the surfaces of partially ingested pseudohyphae, which then appeared damaged. Using a new assay which measured neutrophil-induced inhibition of uptake of [(14)C]cytosine by Candida, damage to Candida in the absence of serum was 53.04+/-2.96% by neutrophils from 27 normal subjects. With serum, damage to Candida increased because of opsonization by low levels of anti-Candida immunoglobulin G in normal sera. Damage to Candida was inhibited by colchicine, cytochalasin B, and 2-deoxyglucose, which interfered with spreading of neutrophils over the surfaces of Candida. Dibutyryl cyclic AMP, theophylline, and isoproterenol also inhibited damage to Candida. Hydrocortisone was inhibitory in levels (10 muM) achievable with pharmacologic doses in man. Light, fluorescence, and electron microscopy indicated that neutrophils degranulated after contact with Candida. Quantitative studies revealed only a minimal increase in specific release of lysosomal enzymes from azurophil granules, but much greater release of lysozyme from specific granules. Candida activated neutrophil oxidative microbicidal mechanisms, as shown by iodination of Candida by neutrophils, and chemiluminescence from neutrophils interacting with Candida. Unlike live Candida, killed Candida did not induce chemiluminescence, were not iodinated, and did not attach to neutrophils by microscopy. Like Candida pseudohyphae, contact between neutrophils and hyphal forms of Aspergillus and Rhizopus occurred in the absence of serum. This did not occur with Cryptococcus neoformans, an encapsulated yeast, and was low with Candida yeasts. These findings indicate that neutrophils can recognize and attach to Candida pseudohyphae, then damage the Candida. This may represent a general reaction between neutrophils and large forms of fungi. Though the size of the organisms precludes complete ingestion, neutrophil oxidative microbicidal mechanisms are activated, and preferential release of contents of specific granules appears to occur.